Showing results (1-10 of 2,911) with videos related to
Sort By:
Pageof 292
Internal Medicine Journal|August 2, 2001
Cyclooxygenase inhibitors: any reservations?P S Penglis, M J James, L G ClelandThe Medical Journal of Australia|October 6, 2001
COX-2 inhibition and thrombotic tendency: a need for surveillanceL G Cleland, M J James, L K Stamp, et al.Seminars in Arthritis and Rheumatism|November 9, 2000
Genetic susceptibility and the link between cat exposure and rheumatoid arthritisP S Penglis, C Bond, I Humphreys, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 21, 2001
Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?M J James, P S Penglis, G E Caughey, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitorsP S Penglis, L G Cleland, M Demasi, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2G E Caughey, L G Cleland, P S Penglis, et al.The Journal of Experimental Medicine|April 1, 1992
Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in ratsS Yoshino, L G ClelandSeminars in Arthritis and Rheumatism|April 1, 1996
Rheumatoid arthritis: are pets implicated in its etiology?C Bond, L G ClelandAgents and Actions. Supplements|January 1, 1985
Reactive oxygen species and drug therapy for inflammatory diseasesM W Whitehouse, L G ClelandThe Journal of Rheumatology|January 1, 1978
The occurrence of systemic lupus erythematosus in two kindreds in association with selective IGA deficiencyL G Cleland, D A BellPageof 292